Christopher J. Langmead

Also affiliated with PYC Therapeutics (Australia)

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Structure-based development of a subtype-selective orexin 1 receptor antagonist”.

Structure-based development of a subtype-selective orexin 1 receptor antagonist

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2002704117

N/A

0DataRank · unranked

54 citations

Matthäus Drabek, Jie Yin, Jakub Gunera, Theresa Pröll, Frank Kraus +7 more

Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents

Biological Psychiatry(2020)10.1016/j.biopsych.2020.02.019

N/A

0DataRank · unranked

50 citations

Alice E. Berizzi, Nicola A. Chen, Patricia Rueda, Victoria M. Perreau, Katherine Huckstep +10 more